Gainers

• Bullfrog AI Hldgs (NASDAQ:BFRG) stock rose 175.4% to $1.4 during Monday's regular session. The market value of their outstanding shares is at $6.4 million.
• Iterum Therapeutics (NASDAQ:ITRM) stock increased by 103.65% to $0.07. The company's market cap stands at $1.8 million.
• SeaStar Medical Holding (NASDAQ:ICU) stock rose 30.29% to $3.57. The company's market cap stands at $10.4 million. The company's, Q4 earnings came out 3 days ago.
• China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 24.62% to $1.62. The company's market cap stands at $1.1 million.
• Apollomics (NASDAQ:APLM) stock rose 23.98% to $21.4. The market value of their outstanding shares is at $37.0 million.
• Kezar Life Sciences (NASDAQ:KZR) shares moved upwards by 19.19% to $7.39. The market value of their outstanding shares is at $45.4 million.

Losers

• Scienture Holdings (NASDAQ:SCNX) stock declined by 37.6% to $0.26 during Monday's regular session. The market value of their outstanding shares is at $16.9 million. As per the press release, Q4 earnings came out today.
• Viridian Therapeutics (NASDAQ:VRDN) shares declined by 33.36% to $18.25. The market value of their outstanding shares is at $2.6 billion.
• GlucoTrack (NASDAQ:GCTK) shares decreased by 32.42% to $0.67.
• Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares declined by 28.05% to $0.29. The market value of their outstanding shares is at $2.9 million.
• Icecure Medical (NASDAQ:ICCM) shares decreased by 25.02% to $0.28. The market value of their outstanding shares is at $27.4 million.
• Insight Molecular (NASDAQ:IMDX) stock declined by 21.92% to $2.78. The market value of their outstanding shares is at $114.5 million. As per the news, the Q4 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.